Volequin injection

Dexa Medica

Ingredients in every ml

Levofloxacin 5 mg

Each package contains

1 bottle of 100 ml

Other details

Dosage form:Injection
Flavour None

W.H.O. classification

ATC Level 1 J - Antiinfectives for systemic use
ATC Level 2 J01 - Antibacterials for Systemic Use
ATC Level 3 J01M - Quinolone Antibacterials

Warnings

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Available in

Cambodia

Dosage information

FOR ALL AGES
For the parenteral and oral dosage forms showing a bioequivalence, the same dosage can be used, usually for 7-14 days depending on severity of the disease.
Usual dosage in patients with normal renal function (creatinine clearance >80 ml/minute) is 250-500 mg once daily depending on type and severity of the infection and sensitivity of the pathogens.
It is usually possible to switch from initial intravenous treatment to the oral route after a few days, according to the condition of the patient.

ELDERLY PATIENTS
Elderly patients (with normal renal function) should receive the same dosage as normal adult patients.

PATIENTS WITH IMPAIRED HEPATIC FUNCTION
Patients with impaired hepatic function (but with normal renal function) should receive the same dosage as normal adult patients.

Indication

Levofloxacin injection is indicated when intravenous administration offers a route administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin is indicated in Adults (≥18 years) in infections with susceptible microorganism, such as:
– Acute maxillary sinusitis.
– Acute bacterial exacerbations of chronic bronchitis.
– Pneumonia (community-acquired pneumonia).
– Uncomplicated skin and skin structure infections.
– Complicated urinary tract infection.
– Acute pyelonephritis.
If bacterial resistance occurs and the result of the therapy does not satisfy, the bacterial monitoring needs to be performed.